Share on LinkedInShare on LinkedIn

ARTICLE · 13 OCTOBER 2021

Notes From New York Cannabis Control Board Meeting, October 2021

Duane Morris LLP
Duane Morris LLP
Contributor
Explore more from Duane Morris LLP

There were several outcomes of the inaugural New York Cannabis Control Board (CCB) Meeting held on October 5, 2021.

United StatesCannabis & Hemp

There were several outcomes of the inaugural New York Cannabis Control Board (CCB) Meeting held on October 5, 2021. The Meeting revealed that the CCB and the Office of Cannabis Management (OCM) will be increasing their staff and taking steps to extend the medical cannabis program and cannabinoid hemp licensing. Also during the Meeting, Jason Starr was announced and voted in as the Chief Equity Officer of the OCM. He will work with Executive Director Chris Alexander in building New York's social equity program.

Medical Marijuana Program Extension

As discussed during the Meeting, the management of New York's medicinal cannabis program will be transferred from the Department of Health (DOH) to the OCM. In practice, the OCM is undertaking the following steps, all of which will take effect immediately: (i) under state legislation, anybody legally authorized to prescribe a restricted drug may now prescribe marijuana; (iii) the maximum marijuana supply for patients has

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

Disclaimer: This Alert has been prepared and published for informational purposes only and is not offered, nor should be construed, as legal advice. For more information, please see the firm's full disclaimer.

See more popular content from